mortality/aging
• only 20% of expected mice from the fourth generation on this background are alive at birth unlike on a congenic FVB background in which mice survive normally or on a congenic C57BL/6 background in which nearly all mice die perinatally
|
cellular
aneuploidy
(
J:143035
)
• 76% of mouse embryonic fibroblasts exhibit aneuploidy compared to 9% of wild-type cells
|
• mouse embryonic fibroblast cells exhibit increases in spindle assembly and chromosome congression defects compared to wild-type cells
|
• nocodazole-treated mouse embryonic fibroblasts exhibit only a modestly lower increase in mitotic index compared to similarly treated wild-type cells
|
• taxol-treated mouse embryonic fibroblasts exhibit severe defects in spindle assembly checkpoints compared to in similarly treated wild-type cells
|
• mouse embryonic fibroblast cells exhibit increases in spindle assembly defects
|
• mouse embryonic fibroblasts exhibit impaired growth compared to wild-type cells
|
• mouse embryonic fibroblasts exhibit higher rates of senescence compared to wild-type cells
|
neoplasm
• the majority of tumors are of liver origins
|
• 76% of mice develop tumors by 23 to 25 months of age compared to 28% of wild-type mice
|
• 16% of mice develop lung tumors compared to no wild-type mice
|
liver/biliary system
• the majority of tumors are of liver origins
|
respiratory system
• 16% of mice develop lung tumors compared to no wild-type mice
|